Trade Mark Director
Chartered Trade Mark Attorney
This site uses cookies
Some of the cookies we use are essential, while others help us to improve your experience by collecting information about how our website is being used.
To find out more about the cookies we use, please see our Cookie Notice.
For information on how we collect, use and manage personal data, please see our Privacy Notice.
Cookie preferences
This website uses cookies to find out how it's being used, and to enhance our visitors' online experience. For more detailed information about how and why we use cookies, take a look at our Cookie Notice. To receive the best possible user experience, we recommend enabling all cookies below. However, if you would like to opt out of certain cookies, you can do so. You can change and update your cookie preferences at any time in our Cookie Notice.
Necessary cookies (required)
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies
Analytical cookies help us to improve our website by collecting and reporting information on its usage.
The Life Sciences sector is one of rapid advancement and growth. Since the turn of the century, annual worldwide revenue in the pharmaceutical industry alone has grown by more than a trillion dollars. With the expansion of such large potential international markets and demand for products growing, novel inventions and the intellectual property protecting them can form extremely valuable additions to company portfolios.
Our team's knowledge of the sector and its various disciplines is built upon years of first-hand, international research in, and understanding of, multi-disciplinary collaborations, as well as our extensive legal expertise. With practical experience in areas from microbial wastewater management to parasitology and genomic sequencing, we offer our clients the insight, knowledge and skills that allow us to identify the key inventive concepts of their inventions. This allows us to acquire for them the broadest protection possible for everything from iterative advances to flagship portfolio products.
We have helped countless clients in the pharmaceuticals industry acquire IP protection for a wide range of drugs. These include medicaments suitable for use in treatment of genetic disorders and cancers, as well as the processes required to prepare them. Furthermore, we can help our clients benefit from the knowledge that the industry thrives on newly identified applications and dosage regimens of known drugs, thus rewarding their continued efforts to advance the various disciplines the industry encompasses.
In a field where the right market-authorised medicinal product could potentially be worth millions of pounds per day, we can also help our clients acquire and maintain Supplementary Protection Certificates to ensure maximal longevity in, and revenue resulting from, their intellectual property.
Beyond pharmaceuticals, WP Thompson has been involved in protecting biotechnological breakthroughs which have contributed to the dramatic advances made in a variety of fields over the decades. These range from human and animal disease vector disruptors, through probiotic and prebiotic compositions, to processes for isolating health supplements and food additives such as natural sweeteners.
We can also guide our clients through the delicate balance that must be struck when acquiring protection of, for example, synthetic nucleic acid and protein sequences and their uses, in order to achieve a level of protection that benefits both our clients and the advancement of their field as a whole.
Documents
01.11.2021
General - 135kb PDF Senior Leaders' Pledge
29.07.2021
General - 136kb PDF Senior Leaders' Pledge
29.07.2021
General - 136kb PDF Senior Leaders' Pledge
29.07.2021
General - 82kb PDF Senior Leaders' Pledge
Links
What do we do?
Design registration allows for the protection of the appearance of your products, your logos and even the surface decoration which is applied to your product range. Before you disclose your design, you should seek advice from our Attorneys on what is, and is not protectable.
Our Patent and Trade Mark Attorneys can advise on the importance of building design protection into your IP strategy and are able to offer the following services:
If you need help and advice with design registration, contact one of our Attorneys today to see how we can offer our expertise to your intellectual property safeguarding strategy.
Once your IP is protected, it is essential that any third party use without your consent is identified and addressed. While there are many routes to resolution of IP disputes, litigation is an option that must be taken in certain circumstances.
Our Patent and Trade Mark Attorney teams have a wealth of experience in High Court and Intellectual Property Enterprise Court litigation and act on behalf of our clients to ensure their rights are protected.
Our attorneys have Litigator Certificates which expand the options available to clients when the potential for litigation arises. We also have strong ties with IP litigators in territories worldwide, should infringement of your IP occur outside of the UK, so you can rest assured that with WP Thompson, your intellectual property interests are covered.
If you've had an idea and want to turn it into a commercial asset by patenting it, our team of UK and European patent attorneys are here to help you, whatever the technology. Patents provide protection for technical innovation in products, processes, materials and machinery. They can also protect software-related developments. Investment in research, development and marketing should all be protected and patents can prove particularly useful for this purpose. Although they are commonly referred to as an intangible asset, patents can generate revenue streams for their owners and can be sold or mortgaged much like any tangible asset. For instance, protecting new concepts via patent may prevent competitors from entering a particular technical space, thereby potentially giving the patent owner an edge over its competitors.
At WP Thompson, we know the value of securing a patent and how important they are as business assets. This is why our advice to clients always takes into consideration the potential financial value of your invention and underpins our approach to the scope of protection our clients require.
Licensing patents you own for use by third parties is another method to generate revenue streams which some clients employ. This is known as out-licensing. However, innovators can also turn the IP of others into commercial products by licensing third-party patents - known as in-licensing. Additionally, patent owners should consider enforcement of existing patent rights as a potential revenue stream.
Your patent portfolio - even those which are yet to reach a commercial stage - is valuable and as such, you should take steps to police it to protect your assets from possible infringement. Our skilled and experienced Patent Attorneys can offer all the help and advice you need to keep the value of your ideas safe. Our team of Attorneys offer our clients a comprehensive range of patent services across all technical disciplines, including chemistry, chemical engineering, electronics, software, fintech, AI, mechanical engineering, medicinal chemistry, medical devices, physics, pharma and biotech.
In addition to the drafting, filing and prosecuting of patent applications, we offer advice and assistance in the strategic assessment of patent portfolios, due diligence investigations, and the provision of patent audits. Our attorneys have broad experience in litigation and contentious issues involving questions of validity, infringement and ownership in particular. We also provide input in relation to commercial negotiations, particularly those involving licences and assignments. Whatever your sector or invention, we have a dedicated team who can provide help, advice and expertise to safeguard your ideas and ensure you can exploit their commercial value to the fullest.
The nature, geographical extent and timing of IP protection varies depending on the nature of a client's business, budget and commercial priorities.
We understand that not all clients are the same and we form a close relationship with you in order to understand your technical and business needs before providing strategic advice on the form and extent of IP protection to pursue.
We maintain a longstanding involvement in our client's IP from inception, to completion of protection and conduct regular reviews to ensure that no gaps exist.
Our strategic advice also extends to enforcement and licensing strategies to ensure that clients maximise the leverage and return sought from investments and resulting IP.
The long-awaited Unitary Patent system is due to enter into force on 1 June 2023, and the implementation roadmap has been published by the UPC preparatory team. The system will increase options available for the geographical extent of patent coverage in Europe from European patent applications.
The Unitary Patent system consists of:
Unitary patent protection can be obtained only for a European patent granted on or after the date on which the Unitary Patent Regulation comes into force (i.e. 1 June 2023), but requests for unitary effect can be filed before this date.
An initial 85 judges who will sit in the UPC have been appointed. The 85 judges include the Presidium of 8 presiding judges who will lead both the Court of Appeal and Court of First Instance, with Klaus Grabinski appointed as president of the Court of Appeal and Florence Butin taking on the role of president of the Court of First Instance.
The judges include legally and technically qualified people from across many of the member states of the UPC, including appointees from Germany, France, Italy, the Netherlands, Belgium, Denmark, Sweden, Finland, Bulgaria, Austria, Portugal, Slovenia and Estonia.
Detailed explanation of the Unified Patent Court, opt-out procedures and obtaining a unitary patent may be found here.
Partner
Chartered and European Patent Attorney | Design Attorney | UPC Representative
Support
London Office Manager | London Records Manager | Certified CIPA & CITMA Paralegal
Partner
Chartered and European Patent Attorney | Design Attorney | Trade Mark Attorney | UPC Representative
Partner
Chartered and European Patent Attorney | Design Attorney | UPC Representative
Partner
Chartered Patent Attorney and European Patent Attorney | Design Attorney | UPC Representative
04.05.2023
Life Sciences
With more than 70 countries across the world setting net zero greenhouse gas emissions targets[1], there is an increasing global effort to mitigate the impact of these gases, released by human industry, into the environment. A key aspect of this goal is to identify methods of reducing levels of greenhouse gases, such as CO2, that are already present in the atmosphere.
Full story17.03.2023
Life Sciences, Chemistry
A recent High Court decision, [2022] EWHC 2847 (Pat), between claimants Teva and defendants Novartis provides clarity on how the inventive concept of a patent is to be interpreted under UK law.
Hacon HHJ, who heard the case, ruled that the invention of a patent is defined specifically by the claims, thus any features present in the claims must contribute to or embody the inventive concept of the invention and any features not present within the claims correspondingly cannot.
Full story18.10.2022
Software, Plant Varieties, Medical Technologies, Materials, Life Sciences, Engineering, Electronics and Telecoms, Consumer Goods, Chemistry, Artificial Intelligence
We previously reported three EPO Technical Board of Appeal (TBA) Decisions T1463/11, T1658/15, and T0144/11 which related to the assessment of inventive step for inventions covering a mix of technical and non-technical features. In the first two decisions, the EPO introduced the concept of a "notional business person". The third decision provided additional guidance on the use of its meaning.
Full story14.10.2022
Software, Plant Varieties, Medical Technologies, Materials, Life Sciences, Engineering, Electronics and Telecoms, Creative and Brands, Consumer Goods, Chemistry, Artificial Intelligence
A unique feature of determining the actual response deadline to Communications, such as Examination Reports, notified by the European Patent Office (EPO) is that the number of months cited in the Communication runs from the 'notification' of the Communication rather than its date.
Full story
10.10.2022
Software, Plant Varieties, Medical Technologies, Materials, Life Sciences, Engineering, Electronics and Telecoms, Creative and Brands, Consumer Goods, Chemistry, Artificial Intelligence
We are delighted to celebrate our ranking as a leading Intellectual Property firm in this year's The Legal 500 (Legalease) – a testament to the quality of services we continue to provide to our clients.
Full story
29.09.2022
Software, Plant Varieties, Medical Technologies, Materials, Life Sciences, Engineering, Electronics and Telecoms, Creative and Brands, Consumer Goods, Chemistry, Artificial Intelligence
A unique feature of determining the actual response deadline to Communications, such as Examination Reports, notified by the European Patent Office (EPO) is that the number of months cited in the Communication runs from the 'notification' of the Communication rather than its date.
Full story13.05.2022
Software, Plant Varieties, Medical Technologies, Materials, Life Sciences, Engineering, Electronics and Telecoms, Creative and Brands, Consumer Goods, Chemistry, Artificial Intelligence
A unique feature of determining the actual response deadline to Communications, such as Examination Reports, notified by the European Patent Office (EPO) is that the number of months cited in the Communication runs from the 'notification' of the Communication rather than its date.
Full story20.04.2022
Life Sciences, Chemistry
Dr Ian Wilson, from our Chemical/Pharma team, looks at the key considerations for researchers considering patent protection, and offers updated insight into the question of the use of data to support a patent filing.
Full story09.12.2021
Life Sciences
WP Thompson Intellectual Property are pleased to note that their client, Sports & Well-Being Analytics, have yet again been featured in the press with respect to their contribution to the success of premiership rugby team Harlequins. Congratulations not only to Harlequins for their league success but also to Sports & Well-Being Analytics for bringing their vision to practical fruition and application.
Full story31.03.2021
Software, Plant Varieties, Medical Technologies, Materials, Life Sciences, Engineering, Electronics and Telecoms, Creative and Brands, Consumer Goods, Chemistry, Artificial Intelligence
The EPO's Enlarged Board of Appeal has been considering questions relating to the patentability of simulations in G1/19 and has recently issued its decision.
Full story14.07.2020
Software, Plant Varieties, Medical Technologies, Materials, Life Sciences, Engineering, Electronics and Telecoms, Creative and Brands, Consumer Goods, Chemistry, Artificial Intelligence
The Italian Patent and Trademark Office have confirmed that, as of 1 July 2020, PCT applicants may enter the national phase in Italy directly. This marks a change from the previous regime, which required applicants to first enter the European regional phase in order to obtain a granted European patent, which could subsequently be validated in Italy.
Full story21.06.2020
Plant Varieties, Life Sciences
WPT very happy to learn that one of its clients recently featured in a UKIPO blog revealing the relevence of IP and innovation to World Oceans Day 2020.
Full storySectors
Electronics and TelecomsLife SciencesPlant VarietiesArtificial IntelligenceSoftwareMedical TechnologiesCreative and BrandsChemistryEngineeringMaterialsQuick contact
Thank you.
We will respond to you as quickly as we can.
Seen enough?
Enquire online
Thank you.
We will respond to you as quickly as we can.
Contact one of our offices
Speak to someone specific
Join our mailing list
Thank you.
© WP Thompson 2024
Website by Storm12